Entry |
|
Symbol |
BCL2
|
Name |
(RefSeq) apoptosis regulator Bcl-2
|
KO |
K02161 | apoptosis regulator Bcl-2 |
|
Organism |
fca Felis catus (domestic cat)
|
Pathway |
fca01521 | EGFR tyrosine kinase inhibitor resistance |
fca04141 | Protein processing in endoplasmic reticulum |
fca04261 | Adrenergic signaling in cardiomyocytes |
fca04621 | NOD-like receptor signaling pathway |
fca04928 | Parathyroid hormone synthesis, secretion and action |
fca04933 | AGE-RAGE signaling pathway in diabetic complications |
fca05022 | Pathways of neurodegeneration - multiple diseases |
fca05168 | Herpes simplex virus 1 infection |
fca05170 | Human immunodeficiency virus 1 infection |
fca05207 | Chemical carcinogenesis - receptor activation |
fca05418 | Fluid shear stress and atherosclerosis |
|
Brite |
KEGG Orthology (KO) [BR:fca00001]
09120 Genetic Information Processing
09123 Folding, sorting and degradation
04141 Protein processing in endoplasmic reticulum
493934 (BCL2)
09130 Environmental Information Processing
09132 Signal transduction
04340 Hedgehog signaling pathway
493934 (BCL2)
04630 JAK-STAT signaling pathway
493934 (BCL2)
04064 NF-kappa B signaling pathway
493934 (BCL2)
04066 HIF-1 signaling pathway
493934 (BCL2)
04071 Sphingolipid signaling pathway
493934 (BCL2)
04151 PI3K-Akt signaling pathway
493934 (BCL2)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
493934 (BCL2)
09143 Cell growth and death
04210 Apoptosis
493934 (BCL2)
04215 Apoptosis - multiple species
493934 (BCL2)
04217 Necroptosis
493934 (BCL2)
04115 p53 signaling pathway
493934 (BCL2)
09144 Cellular community - eukaryotes
04510 Focal adhesion
493934 (BCL2)
09150 Organismal Systems
09151 Immune system
04621 NOD-like receptor signaling pathway
493934 (BCL2)
09152 Endocrine system
04915 Estrogen signaling pathway
493934 (BCL2)
04928 Parathyroid hormone synthesis, secretion and action
493934 (BCL2)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
493934 (BCL2)
09156 Nervous system
04725 Cholinergic synapse
493934 (BCL2)
04722 Neurotrophin signaling pathway
493934 (BCL2)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
493934 (BCL2)
05206 MicroRNAs in cancer
493934 (BCL2)
05207 Chemical carcinogenesis - receptor activation
493934 (BCL2)
09162 Cancer: specific types
05210 Colorectal cancer
493934 (BCL2)
05226 Gastric cancer
493934 (BCL2)
05215 Prostate cancer
493934 (BCL2)
05222 Small cell lung cancer
493934 (BCL2)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
493934 (BCL2)
05161 Hepatitis B
493934 (BCL2)
05162 Measles
493934 (BCL2)
05168 Herpes simplex virus 1 infection
493934 (BCL2)
05169 Epstein-Barr virus infection
493934 (BCL2)
09171 Infectious disease: bacterial
05132 Salmonella infection
493934 (BCL2)
05152 Tuberculosis
493934 (BCL2)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
493934 (BCL2)
09164 Neurodegenerative disease
05014 Amyotrophic lateral sclerosis
493934 (BCL2)
05022 Pathways of neurodegeneration - multiple diseases
493934 (BCL2)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
493934 (BCL2)
05418 Fluid shear stress and atherosclerosis
493934 (BCL2)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
493934 (BCL2)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
493934 (BCL2)
01524 Platinum drug resistance
493934 (BCL2)
01522 Endocrine resistance
493934 (BCL2)
09180 Brite Hierarchies
09181 Protein families: metabolism
01009 Protein phosphatases and associated proteins [BR:fca01009]
493934 (BCL2)
Protein phosphatases and associated proteins [BR:fca01009]
Protein serine/threonine phosphatases
Phosphoprotein phosphatases (PPPs)
Protein phosphatase-1
PP1-interacting proteins (PIPs)
493934 (BCL2)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
D3:complement(80776548..80953959)
|
AA seq |
235 aa
MAHAGRTGYDNREIVMKYIHYELPQRGYEWDAGDAGAAPPGAAPAPGIFSSQPGRTPAPA
RTSPPPPPVAPAAAAAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPF
TARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVEGVNREMSPLVDNIALWMTEYLNRH
LHTWIQDNGGWDAFVELYGPSMQPLFDFSWLSLKALLSLALVGACITLGAYLGHK |
NT seq |
708 nt +upstreamnt +downstreamnt
atggcgcacgctgggagaacagggtatgataaccgggagatagtgatgaagtacatccac
tatgagctgccgcagaggggctacgagtgggatgccggggacgcgggcgccgcgcccccg
ggggccgcccccgcgccgggcatcttctcctcccagcccgggcgcacccctgcgcccgcc
aggacctccccgccgccgcccccggtcgcccccgccgccgccgccgctgccgcgggccct
gcgctcagccccgtgccacctgtggtccacctgaccctgcgccaggccggcgatgacttc
tcccgtcgctaccgccgcgacttcgcggagatgtccagccagctgcacctgacacccttt
accgcaaggggacgctttgccacggtggtggaggagctcttcagggatggcgtgaactgg
gggaggattgtggccttctttgagttcggtggggtcatgtgtgtggagggcgtcaaccga
gagatgtcgcccctggtggacaacatcgccctgtggatgactgagtacctgaaccggcac
ctgcacacctggatccaggataacggaggctgggatgcctttgtggaactgtacggcccc
agcatgcagcctctgtttgatttctcctggctgtccctgaaggccctgctcagtctggcc
ctggtgggggcttgcatcaccctgggtgcctatctgggccacaagtga |